bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 12, 2023
Abstract
Tau
is
a
microtubule
associated
protein
that
plays
important
roles
in
regulating
the
properties
of
microtubules
and
axonal
transport,
as
well
tauopathies
with
toxic
aggregates
leading
to
neurodegenerative
diseases.
It
encoded
by
MAPT
gene
forming
multiple
isoforms
alternative
splicing
exons
2/3
at
N-terminal
exon
10
which
determines
numbers
binding
repeats
(3R
or
4R).
The
high
molecular
weight
(MW)
tau
isoform
termed
Big
contains
an
additional
large
4a
generating
long
projecting
domain
expressed
110
kDa
protein.
was
originally
discovered
peripheral
nervous
system
but
later
found
selective
CNS
areas
project
periphery
cerebellum
visual
system.
However,
there
gap
knowledge
understanding
expression
patterns
role
during
normal
neuronal
development
pathological
conditions
relative
common
low
MW
isoforms.
Here
we
investigated
retina
optic
nerve
particular
its
unique
structure
middle
90kDa
distribution
retinal
ganglion
cells
axons
nerve.
We
expresses
6
(4R),
lacking
sharing
extensive
phosphorylation
characteristic
other
Importantly,
early
only
(3R)
switching
both
(4R)
adult
neurons
their
corresponding
axons.
This
pattern
likely
different
than
what
has
been
previously
described,
requiring
more
research
elucidate
detailed
Alzheimer s & Dementia,
Journal Year:
2024,
Volume and Issue:
20(5), P. 3606 - 3628
Published: March 31, 2024
Alternative
splicing
of
the
human
MAPT
gene
generates
six
brain-specific
TAU
isoforms.
Imbalances
in
isoform
ratio
can
lead
to
neurodegenerative
diseases,
underscoring
need
for
precise
control
over
balance.
Tauopathies,
characterized
by
intracellular
aggregates
hyperphosphorylated
TAU,
exhibit
extensive
neurodegeneration
and
be
classified
isoforms
present
pathological
accumulations.
Neurotherapeutics,
Journal Year:
2024,
Volume and Issue:
21(2), P. e00321 - e00321
Published: Jan. 25, 2024
The
tauopathies
encompass
over
20
adult
neurodegenerative
diseases
and
are
characterized
by
the
dysfunction
accumulation
of
insoluble
tau
protein.
Among
them,
Alzheimer's
disease,
frontotemporal
dementia,
progressive
supranuclear
palsy
collectively
impact
millions
patients
their
families
worldwide.
Despite
years
drug
development
using
a
variety
mechanisms
action,
no
therapeutic
directed
against
has
been
approved
for
clinical
use.
This
raises
important
questions
about
our
current
model
pathology
invites
thoughtful
consideration
approach
to
nonclinical
models
trial
design.
In
this
article,
we
review
what
is
known
biology
genetics
tau,
placing
it
in
context
failed
trials.
We
highlight
potential
reasons
lack
success
date
offer
suggestions
new
pathways
development.
Overall,
viewpoint
future
optimistic
group
diseases.
Journal of Neurology,
Journal Year:
2024,
Volume and Issue:
271(6), P. 2992 - 3018
Published: March 30, 2024
Abstract
Tauopathies
are
a
heterogeneous
group
of
neurologic
diseases
characterized
by
pathological
axodendritic
distribution,
ectopic
expression,
and/or
phosphorylation
and
aggregation
the
microtubule-associated
protein
TAU,
encoded
gene
MAPT
.
Neuronal
dysfunction,
dementia,
neurodegeneration
common
features
these
often
detrimental
diseases.
A
neurodegenerative
disease
is
considered
primary
tauopathy
when
mutations/haplotypes
its
cause
TAU
main
feature.
In
case
pathology
observed
but
superimposed
another
hallmark,
condition
classified
as
secondary
tauopathy.
some
tauopathies
(e.g.
-associated
frontotemporal
dementia
(FTD),
progressive
supranuclear
palsy
(PSP),
corticobasal
degeneration
(CBD),
Alzheimer's
(AD))
recognized
significant
pathogenic
driver
disease.
many
tauopathies,
including
Parkinson's
(PD)
Huntington's
(HD),
suggested
to
contribute
development
in
others
Niemann-Pick
(NPC))
may
only
be
bystander.
The
genetic
mechanisms
underlying
not
fully
understood.
this
review,
predispositions
variants
associated
with
both
examined
detail,
assessing
evidence
for
role
conditions.
We
highlight
less
forms
increase
awareness
disorders
involvement
their
pathology.
This
approach
contributes
deeper
understanding
conditions
also
lay
groundwork
potential
TAU-based
therapeutic
interventions
various
tauopathies.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(9), P. 4969 - 4969
Published: May 2, 2024
Tau
protein
misfolding
and
aggregation
are
pathological
hallmarks
of
Alzheimer's
disease
over
twenty
neurodegenerative
disorders.
However,
the
molecular
mechanisms
tau
in
vivo
remain
incompletely
understood.
There
two
types
aggregates
brain:
soluble
(oligomers
protofibrils)
insoluble
filaments
(fibrils).
Compared
to
filamentous
aggregates,
more
toxic
exhibit
prion-like
transmission,
providing
seeds
for
templated
misfolding.
Curiously,
its
native
state,
is
a
highly
soluble,
heat-stable
that
does
not
form
fibrils
by
itself,
even
when
hyperphosphorylated.
In
vitro
studies
have
found
negatively
charged
molecules
such
as
heparin,
RNA,
or
arachidonic
acid
generally
required
induce
aggregation.
Two
recent
breakthroughs
provided
new
insights
into
mechanisms.
First,
an
intrinsically
disordered
protein,
undergo
liquid-liquid
phase
separation
(LLPS)
both
inside
cells.
Second,
cryo-electron
microscopy
has
revealed
diverse
fibrillar
conformations
associated
with
different
Nonetheless,
only
core
structurally
resolved,
remainder
appears
"fuzzy
coat".
From
this
review,
it
further
(1)
clarify
role
LLPS
aggregation;
(2)
unveil
structural
features
aggregates;
(3)
understand
involvement
fuzzy
coat
regions
oligomer
fibril
formation.
Acta Neuropathologica,
Journal Year:
2024,
Volume and Issue:
147(1)
Published: May 18, 2024
Antibodies
are
essential
research
tools
whose
performance
directly
impacts
conclusions
and
reproducibility.
Owing
to
its
central
role
in
Alzheimer's
disease
other
dementias,
hundreds
of
distinct
antibody
clones
have
been
developed
against
the
microtubule-associated
protein
Tau
multiple
proteoforms.
Despite
this
breadth
offer,
limited
understanding
their
poor
selectivity
hindered
progress.
Here,
we
validate
a
large
panel
antibodies
by
Western
blot
(79
reagents)
immunohistochemistry
(35
reagents).
We
address
reagents'
ability
detect
target
proteoform,
selectivity,
impact
phosphorylation
on
binding
human
brain
samples.
While
most
detected
at
high
levels,
many
failed
it
lower,
endogenous
levels.
By
WB,
non-selective
proteins
affected
over
half
tested,
with
several
cross-reacting
related
MAP2
protein,
whereas
"oligomeric
Tau"
T22
reacted
monomeric
thus
calling
into
question
specificity
oligomers.
presumption
that
"total"
agnostic
post-translational
modifications,
found
partially
inhibits
for
such
antibodies,
including
popular
Tau-5
clone.
further
combine
high-sensitivity
reagents,
mass-spectrometry
proteomics
cDNA
sequencing
demonstrate
presumptive
"knockout"
cells
continue
express
residual
arising
through
exon
skipping,
providing
evidence
previously
unappreciated
gene
plasticity.
Finally,
probing
samples
revealed
presence
C-term-truncated
versions
all
main
isoforms
both
control
tauopathy
donors.
Ultimately,
identify
validated
can
be
employed
blotting
and/or
reliably
even
low
levels
expression
selectivity.
This
work
represents
an
extensive
resource
will
enable
re-interpretation
published
data,
improve
reproducibility
research,
overall
accelerate
scientific
Molecular Neurodegeneration,
Journal Year:
2025,
Volume and Issue:
20(1)
Published: May 10, 2025
Abstract
Tau
protein
plays
a
critical
role
in
the
physiological
functioning
of
central
nervous
system
by
providing
structural
integrity
to
cytoskeletal
architecture
neurons
and
glia
through
microtubule
assembly
stabilization.
Under
certain
pathological
conditions,
tau
is
aberrantly
phosphorylated
aggregates
into
neurotoxic
fibrillary
tangles.
The
aggregation
cell-to-cell
propagation
leads
progressive
deterioration
system.
clinical
entity
traumatic
brain
injury
(TBI)
ranges
from
mild
severe
can
promote
inducing
cellular
mechanisms
signalling
pathways
that
increase
phosphorylation
aggregation.
Chronic
encephalopathy
(CTE),
which
consequence
repetitive
TBI,
unique
tauopathy
characterized
located
at
depths
sulci
surrounding
blood
vessels.
leading
increased
CTE
remain
be
fully
defined
but
are
likely
result
primary
secondary
sequelae
associated
with
TBI.
includes
physical
mechanical
damage
resulting
head
impact
accompanying
forces
cause
blood–brain
barrier
disruption
axonal
shearing,
primes
more
vulnerable
subsequent
mechanisms.
A
complex
interplay
neuroinflammation,
oxidative
stress,
excitotoxicity,
mitochondrial
dysfunction
activate
kinase
cell
death
pathways,
increasing
phosphorylation,
neurodegeneration.
In
this
review,
we
explore
most
recent
insights
TBI
propose
how
multiple
converge
on
may
contribute
progression.
Graphical
Neurology International,
Journal Year:
2025,
Volume and Issue:
17(5), P. 75 - 75
Published: May 13, 2025
Tau
protein
plays
a
pivotal
role
in
maintaining
neuronal
structure
and
function
through
its
regulation
of
microtubule
stability
polarity.
Encoded
by
the
MAPT
gene,
exists
multiple
isoforms
due
to
alternative
mRNA
splicing,
with
differential
expression
central
peripheral
nervous
systems.
In
healthy
neurons,
tau
is
selectively
localized
translated
axons,
process
tightly
regulated
untranslated
regions
(UTRs)
RNA-binding
proteins
such
as
HuD
FMRP.
Pathologically,
undergoes
hyperphosphorylation,
misfolding,
aggregation,
which
contribute
neurodegeneration
range
disorders
collectively
known
tauopathies.
Alzheimer’s
disease
(AD)
most
prevalent
tauopathy,
where
abnormal
accumulation
temporal
frontal
lobes
correlates
cognitive
decline
behavioral
symptoms.
Other
tauopathies,
including
Progressive
Supranuclear
Palsy
(PSP),
Corticobasal
Degeneration
(CBD),
Frontotemporal
Dementia
Parkinsonism
(FTDP-17),
Pick’s
disease,
are
distinguished
predominance
specific
(3R
or
4R),
cellular
distribution,
affected
brain
regions.
Notably,
astroglial
tauopathies
highlight
pathological
glial
cells,
expanding
understanding
beyond
neurons.
Despite
advances
imaging
biomarkers
(e.g.,
Tau-PET)
molecular
diagnostics,
effective
disease-modifying
therapies
for
remain
elusive.
Ongoing
research
targets
immunotherapies,
splicing
modulators,
kinase
inhibitors,
antisense
oligonucleotides,
aiming
mitigate
pathology
deleterious
effects.
Understanding
multifaceted
roles
contexts
critical
developing
future
therapeutic
strategies
against
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(8), P. 938 - 938
Published: Aug. 1, 2024
Frontotemporal
dementia
(FTD)
includes
a
number
of
neurodegenerative
diseases,
often
with
early
onset
(before
65
years
old),
characterized
by
progressive,
irreversible
deficits
in
behavioral,
linguistic,
and
executive
functions,
which
are
difficult
to
diagnose
due
their
similar
phenotypic
characteristics
other
dementias
psychiatric
disorders.
The
genetic
contribution
is
utmost
importance,
although
environmental
risk
factors
also
play
role
its
pathophysiology.
In
fact,
some
metals
known
produce
free
radicals,
which,
accumulating
the
brain
over
time,
can
induce
oxidative
stress,
inflammation,
protein
misfolding,
all
these
being
key
features
FTD
conditions.
Therefore,
present
review
aims
summarize
current
evidence
about
FTD-mainly
dealing
toxic
metal
exposure-since
identification
such
potential
lead
diagnosis
promotion
policies
interventions.
This
would
allow
us,
reducing
exposure
pollutants,
potentially
affect
society
at
large
positive
manner,
decreasing
burden
conditions
on
affected
individuals
overall.
Future
perspectives,
including
application
Artificial
Intelligence
principles
field,
related
found
so
far,
introduced.
Brain,
Journal Year:
2023,
Volume and Issue:
147(4), P. 1399 - 1411
Published: Nov. 16, 2023
Abstract
The
most
frequent
neurodegenerative
proteinopathies
include
diseases
with
deposition
of
misfolded
tau
or
α-synuclein
in
the
brain.
Pathological
protein
aggregates
PNS
are
well-recognized
α-synucleinopathies
and
have
recently
attracted
attention
as
a
diagnostic
biomarker.
However,
there
is
paucity
observations
tauopathies.
To
characterize
involvement
tauopathies,
we
investigated
pathology
cranial
spinal
nerves
(PNS-tau)
54
tauopathy
cases
[progressive
supranuclear
palsy
(PSP),
n
=
15;
Alzheimer’s
disease
(AD),
18;
chronic
traumatic
encephalopathy
(CTE),
5;
corticobasal
degeneration
(CBD),
6;
Pick’s
disease,
9;
limbic-predominant
neuronal
inclusion
body
4-repeat
(LNT),
1]
using
immunohistochemistry,
Gallyas
silver
staining,
biochemistry,
seeding
assays.
Most
PSP
revealed
phosphorylated
immunoreactive
deposits
follows:
(number
tau-positive
cases/available
cases)
III:
7/8
(88%);
IX/X:
10/11
(91%);
XII:
6/6
(100%);
anterior
roots:
10/10
(100%).
inclusions
often
showed
structures
fibrillary
(neurofibrillary
tangle-like)
morphology
axon
that
were
also
recognized
staining.
CBD
rarely
fine
granular
non-argyrophilic
deposits.
In
contrast,
was
not
evident
AD,
CTE
cases.
single
LNT
case
PNS.
PSP,
severity
PNS-tau
correlated
corresponding
nuclei,
although,
occasionally,
p-tau
present
but
related
brainstem
nuclei.
Not
surprisingly,
presented
eye
movement
disorder
bulbar
symptoms,
some
lower-motor
neuron
signs.
Using
biosensor
cells,
for
first
time
demonstrated
capacity
conclusion,
prominent
distinguishes
from
other
morphological
differences
between
suggest
could
reflect
central
nervous
system.
high
frequency
early
presence
lesions
may
clinical
biomarker
relevance.
Cytoskeleton,
Journal Year:
2024,
Volume and Issue:
81(9-10), P. 488 - 499
Published: May 18, 2024
Tau
is
a
microtubule
associated
protein
that
plays
important
roles
in
regulating
the
properties
of
microtubules
and
axonal
transport,
as
well
tauopathies
with
toxic
aggregates
leading
to
neurodegenerative
diseases.
It
encoded
by
MAPT
gene
forming
multiple
isoforms
(45-60
kDa)
alternative
splicing
which
are
developmentally
regulated.
The
high
molecular
weight
(MW)
tau
isoform
105
kDa,
termed
Big
tau,
was
originally
discovered
peripheral
nervous
system
(PNS)
but
later
found
selective
CNS
areas.
contains
an
additional
large
exon
4a
generating
long
projecting
domain
about
250
amino
acids.
Here
we
investigated
visual
rats,
its
distribution
retinal
ganglion
cells
optic
nerve
developmental
regulation
using
biochemical,
histological
analyses.
We
expresses
95
kDa
(termed
middle
MW)
containing
exons
4a,
6
10
defines
4
microtubule-binding
repeats
(4R).
lacks
2/3
shares
extensive
phosphorylation
characteristic
other
isoforms.
Importantly,
early
development
only
low
MW
(3R)
switching
both
(4R)
adult
neurons
their
corresponding
axons.
This
unique
structure
expression
pattern
hypothesize
specific
different
from
what
has
been
previously
described
PNS
areas
system.